U.S., Jan. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07365644) titled 'Prophylactic ANTicoagulation With HEparine in Critically Ill Patients With Renal Impairment' on Jan. 16.
Brief Summary: Intensive care patients have an increased risk of venous thromboembolic events (deep vein thrombosis (DVT) and pulmonary embolism (PE)) due to the presence of general risk factors for thrombosis (age, immobilization, obesity, prothrombotic history, etc.), but also risk factors specifically related to their stay in intensive care (sepsis, vasopressors, organ failure, mechanical ventilation, sedation, renal failure, central venous catheters). In addition, these same patients also have an increased risk of hemorrhagic...